SARS-CoV-2 Spike 抗体
(SARS-CoV-2 Spike (SARS-CoV-2 S))
mediates fusion of the virion and cellular membranes by acting as a class I viral fusion protein. Under the current model, the protein has at least three conformational states: pre-fusion native state, pre-hairpin intermediate state, and post-fusion hairpin state. During viral and target cell membrane fusion, the coiled coil regions (heptad repeats) assume a trimer-of-hairpins structure, positioning the fusion peptide in close proximity to the C-terminal region of the ectodomain. The formation of this structure appears to drive apposition and subsequent fusion of viral and target cell membranes.
| Catalog no. | 产品 | 适用 | 宿主 / 克隆类型 | 应用 | 价格和交货时间 |
|---|---|---|---|---|---|
| SARS-CoV-2 Spike 抗体 (C-Term) | SARS Coronavirus-2 (SARS-CoV-2), SARS Coronavirus (SARS-CoV) | 兔 Polyclonal |
|
|
|
| Recombinant SARS-CoV-2 Spike 抗体 (AA 319-541) | SARS Coronavirus-2 (SARS-CoV-2) | 小鼠 Monoclonal |
|
|
|
| Recombinant SARS-CoV-2 Spike 抗体 (Receptor Binding Domain) (Fc Tag) | SARS Coronavirus-2 (SARS-CoV-2) | Human Monoclonal |
|
|
|
| SARS-CoV-2 Spike 抗体 | SARS Coronavirus-2 (SARS-CoV-2), SARS CoV-2 Alpha, SARS CoV-2 Beta, SARS CoV-2 Gamma | 兔 Polyclonal |
|
|
|
| Recombinant SARS-CoV-2 Spike 抗体 | SARS Coronavirus-2 (SARS-CoV-2) | Human Monoclonal |
|
|
|
| Recombinant SARS-CoV-2 Spike 抗体 | SARS Coronavirus-2 (SARS-CoV-2) | Human Monoclonal |
|
|
|
| Recombinant SARS-CoV-2 Spike 抗体 (AA 16-685) (Fc Tag,HRP) | SARS Coronavirus-2 (SARS-CoV-2) | 小鼠 Monoclonal |
|
|
|
| Recombinant SARS-CoV-2 Spike 抗体 (AA 16-685) | SARS Coronavirus-2 (SARS-CoV-2) | Chimeric Chimeric |
|
|
|
| SARS-CoV-2 Spike 抗体 (RBD) | SARS Coronavirus-2 (SARS-CoV-2) | 兔 Monoclonal |
|
|
|
| Recombinant SARS-CoV-2 Spike 抗体 (AA 16-685) (Fc Tag,Biotin) | SARS Coronavirus-2 (SARS-CoV-2) | 小鼠 Monoclonal |
|
|
|
| Recombinant SARS-CoV-2 Spike 抗体 | SARS Coronavirus-2 (SARS-CoV-2) | Human Monoclonal |
|
|
|
| Recombinant SARS-CoV-2 Spike 抗体 | SARS Coronavirus-2 (SARS-CoV-2) | Human Monoclonal |
|
|
|
| Recombinant SARS-CoV-2 Spike 抗体 | SARS Coronavirus-2 (SARS-CoV-2) | Human Monoclonal |
|
|
|
| Recombinant SARS-CoV-2 Spike 抗体 | SARS Coronavirus-2 (SARS-CoV-2) | Human Monoclonal |
|
|
|
| Recombinant SARS-CoV-2 Spike 抗体 (C-Term, Extracellular Domain, RBD) | SARS Coronavirus-2 (SARS-CoV-2) | 小鼠 Chimeric |
|
|
|
| SARS-CoV-2 Spike 抗体 (RBD) | SARS Coronavirus-2 (SARS-CoV-2) | 山羊 Polyclonal |
|
|
|
| SARS-CoV-2 Spike 抗体 (C-Term) | SARS Coronavirus-2 (SARS-CoV-2) | 兔 Polyclonal |
|
|
|
| SARS-CoV-2 Spike 抗体 | SARS Coronavirus-2 (SARS-CoV-2) | 兔 Monoclonal |
|
|
|
| SARS-CoV-2 Spike 抗体 (RBD) | SARS Coronavirus-2 (SARS-CoV-2) | 兔 Monoclonal |
|
|
|
| SARS-CoV-2 Spike 抗体 (RBD) | SARS Coronavirus-2 (SARS-CoV-2) | 山羊 Polyclonal |
|
|
Primary Antibody
- ELISA (ELISA: 有验证图片)
- WB (Western Blotting: 有验证图片)
- IF (Immunofluorescence: 有验证图片)
- IHC (Immunohistochemistry: 有验证图片)
11 references - 适用
- SARS Coronavirus-2 (SARS-CoV-2), SARS Coronavirus (SARS-CoV)
- 宿主
- 兔
- 克隆形成能力
- Polyclonal
- 标记
- unconjugated
- 抗体亚型
- IgG
- 抗原表位
- C-Term
Primary Antibody
- ELISA (ELISA: 有验证图片)
- IF (Immunofluorescence: 有验证图片)
- WB (Western Blotting: 所列应用)
- FACS (Flow Cytometry: 所列应用)
- 质量等级
- Animal-Free
- 适用
- SARS Coronavirus-2 (SARS-CoV-2)
- 宿主
- 小鼠
- 克隆形成能力
- Monoclonal
- 克隆
- AB68-A09
- 标记
- unconjugated
- 蛋白类型
- Recombinant Antibody
- 抗体亚型
- IgG2a
- 抗原表位
- AA 319-541
Primary Antibody
- ELISA (ELISA: 有验证图片)
- rapid (Rapid Test: 有验证图片)
- Neut (Neutralization: 所列应用)
- GICA (Colloidal Gold Immunochromatography Assay: 所列应用)
- 适用
- SARS Coronavirus-2 (SARS-CoV-2)
- 宿主
- Human
- 克隆形成能力
- Monoclonal
- 克隆
- A1
- 标记
- Fc Tag
- Fragment
- single-domain Antibody (sdAb)
- 蛋白类型
- Recombinant Antibody
- 抗体亚型
- IgG1
- 抗原表位
- AA 319-541, Receptor Binding Domain
Primary Antibody
- ELISA (ELISA: 有验证图片)
- WB (Western Blotting: 有验证图片)
- IF (Immunofluorescence: 有验证图片)
- 适用
- SARS Coronavirus-2 (SARS-CoV-2), SARS CoV-2 Alpha, SARS CoV-2 Beta, SARS CoV-2 Gamma
- 宿主
- 兔
- 克隆形成能力
- Polyclonal
- 标记
- unconjugated
- 抗体亚型
- IgG
Primary Antibody
- ELISA (ELISA: 有验证图片)
- 适用
- SARS Coronavirus-2 (SARS-CoV-2)
- 宿主
- Human
- 克隆形成能力
- Monoclonal
- 克隆
- AM015553 (553-15)
- 标记
- unconjugated
- 蛋白类型
- Recombinant Antibody
- 抗体亚型
- IgG1
Primary Antibody
- ELISA (ELISA: 有验证图片)
- WB (Western Blotting: 有验证图片)
- 适用
- SARS Coronavirus-2 (SARS-CoV-2)
- 宿主
- Human
- 克隆形成能力
- Monoclonal
- 克隆
- AM004414 (414-4)
- 标记
- unconjugated
- 蛋白类型
- Recombinant Antibody
- 抗体亚型
- IgG1
Primary Antibody
- ELISA (ELISA: 有验证图片)
- 适用
- SARS Coronavirus-2 (SARS-CoV-2)
- 宿主
- 小鼠
- 克隆形成能力
- Monoclonal
- 克隆
- H6
- 标记
- Fc Tag,HRP
- Fragment
- scFv fragment
- 蛋白类型
- Recombinant Antibody
- 抗体亚型
- IgG1
- 抗原表位
- AA 16-685
Primary Antibody
- ELISA (ELISA: 有验证图片)
- GICA (Colloidal Gold Immunochromatography Assay: 所列应用)
- 适用
- SARS Coronavirus-2 (SARS-CoV-2)
- 宿主
- Chimeric
- 克隆形成能力
- Chimeric
- 克隆
- H6
- 标记
- unconjugated
- 蛋白类型
- Recombinant Antibody
- 抗体亚型
- Ig kappa, IgG1
- 抗原表位
- AA 16-685
Primary Antibody
- ELISA (ELISA: 有验证图片)
- FACS (Flow Cytometry: 有验证图片)
- 适用
- SARS Coronavirus-2 (SARS-CoV-2)
- 宿主
- 兔
- 克隆形成能力
- Monoclonal
- 克隆
- DM54
- 标记
- unconjugated
- 抗体亚型
- IgG
- 抗原表位
- AA 319-541, RBD
Primary Antibody
- ELISA (ELISA: 有验证图片)
- 适用
- SARS Coronavirus-2 (SARS-CoV-2)
- 宿主
- 小鼠
- 克隆形成能力
- Monoclonal
- 克隆
- H6
- 标记
- Fc Tag,Biotin
- Fragment
- scFv fragment
- 蛋白类型
- Recombinant Antibody
- 抗体亚型
- IgG1
- 抗原表位
- AA 16-685
Primary Antibody
- ELISA (ELISA: 有验证图片)
- FACS (Flow Cytometry: 所列应用)
- 质量等级
- Research Grade
- 适用
- SARS Coronavirus-2 (SARS-CoV-2)
- 宿主
- Human
- 克隆形成能力
- Monoclonal
- 克隆
- CR3022
- 标记
- unconjugated
- 蛋白类型
- Recombinant Antibody
- 抗体亚型
- IgG1
Primary Antibody
- ELISA (ELISA: 有验证图片)
- 适用
- SARS Coronavirus-2 (SARS-CoV-2)
- 宿主
- Human
- 克隆形成能力
- Monoclonal
- 克隆
- CR3022-IgA1
- 标记
- unconjugated
- 蛋白类型
- Recombinant Antibody
- 抗体亚型
- IgA
Primary Antibody
- ELISA (ELISA: 有验证图片)
- 适用
- SARS Coronavirus-2 (SARS-CoV-2)
- 宿主
- Human
- 克隆形成能力
- Monoclonal
- 克隆
- CR3022-IgM
- 标记
- unconjugated
- 蛋白类型
- Recombinant Antibody
- 抗体亚型
- IgM
Primary Antibody
- ELISA (ELISA: 有验证图片)
- 适用
- SARS Coronavirus-2 (SARS-CoV-2)
- 宿主
- Human
- 克隆形成能力
- Monoclonal
- 克隆
- CR3022-IgG1
- 标记
- unconjugated
- 蛋白类型
- Recombinant Antibody
- 抗体亚型
- IgG1
Primary Antibody
- ELISA (ELISA: 有验证图片)
- Inh (Inhibition: 所列应用)
- GCI (Grating Coupled Interferometry: 所列应用)
- 适用
- SARS Coronavirus-2 (SARS-CoV-2)
- 宿主
- 小鼠
- 克隆形成能力
- Chimeric
- 克隆
- Sb#14
- 标记
- unconjugated
- 蛋白类型
- Recombinant Antibody
- 抗体亚型
- IgG1-Fc Fusion
- 抗原表位
- C-Term, Extracellular Domain, RBD
Primary Antibody
- WB (Western Blotting: 有验证图片)
- 适用
- SARS Coronavirus-2 (SARS-CoV-2)
- 宿主
- 山羊
- 克隆形成能力
- Polyclonal
- 标记
- unconjugated
- 抗体亚型
- IgG
- 抗原表位
- RBD
Primary Antibody
- WB (Western Blotting: 有验证图片)
- 适用
- SARS Coronavirus-2 (SARS-CoV-2)
- 宿主
- 兔
- 克隆形成能力
- Polyclonal
- 标记
- unconjugated
- 抗体亚型
- IgG
- 抗原表位
- C-Term
Primary Antibody
- ELISA (ELISA: 有验证图片)
- 适用
- SARS Coronavirus-2 (SARS-CoV-2)
- 宿主
- 兔
- 克隆形成能力
- Monoclonal
- 克隆
- DM25
- 标记
- unconjugated
- 抗体亚型
- IgG
Primary Antibody
- FACS (Flow Cytometry: 有验证图片)
- ELISA (ELISA: 所列应用)
- 适用
- SARS Coronavirus-2 (SARS-CoV-2)
- 宿主
- 兔
- 克隆形成能力
- Monoclonal
- 克隆
- DM26
- 标记
- unconjugated
- 抗体亚型
- IgG
- 抗原表位
- RBD
Primary Antibody
- WB (Western Blotting: 有验证图片)
- ELISA (ELISA: 所列应用)
- 质量等级
- Verified
- 适用
- SARS Coronavirus-2 (SARS-CoV-2)
- 宿主
- 山羊
- 克隆形成能力
- Polyclonal
- 标记
- unconjugated
- 抗原表位
- RBD
Latest Publications for our SARS-CoV-2 Spike 抗体
: "Evidence of Placental Villous Inflammation and Apoptosis in Third-Trimester Symptomatic SARS-CoV-2 Maternal Infection." in: Yonsei medical journal, Vol. 65, Issue 4, pp. 202-209, (2024) (PubMed).
: "A Naïve Phage Display Library-Derived Nanobody Neutralizes SARS-CoV-2 and Three Variants of Concern." in: International journal of nanomedicine, Vol. 18, pp. 5781-5795, (2023) (PubMed).
: "Antibody escape and global spread of SARS-CoV-2 lineage A.27." in: Nature communications, Vol. 13, Issue 1, pp. 1152, (2022) (PubMed).
: "A Structurally Conserved RNA Element within SARS-CoV-2 ORF1a RNA and S mRNA Regulates Translation in Response to Viral S Protein-Induced Signaling in Human Lung Cells." in: Journal of virology, Vol. 96, Issue 2, pp. e0167821, (2022) (PubMed).
: "Within-host evolution of SARS-CoV-2 in an immunosuppressed COVID-19 patient as a source of immune escape variants." in: Nature communications, Vol. 12, Issue 1, pp. 6405, (2021) (PubMed).
: "Enhancing the Stability of COVID-19 Serological Assay through Metal-Organic Framework Encapsulation." in: Advanced healthcare materials, Vol. 10, Issue 18, pp. e2100410, (2021) (PubMed).
: "Rotavirus as an Expression Platform of the SARS-CoV-2 Spike Protein." in: bioRxiv : the preprint server for biology, (2021) (PubMed).
: "Tissue-Based SARS-Cov-2 Detection in Fatal COVID-19 Infections: Sustained Direct Viral-Induced Damage is Not Necessary to Drive Disease Progression. ..." in: Human pathology, (2021) (PubMed).
: "High-throughput fabrication of high aspect ratio Ag/Al nanopillars for optical detection of biomarkers." in: Journal of materials chemistry. B, (2021) (PubMed).
: "Complement associated microvascular injury and thrombosis in the pathogenesis of severe COVID-19 infection: A report of five cases." in: Translational research : the journal of laboratory and clinical medicine, Vol. 220, pp. 1-13, (2020) (PubMed).
: "A Naïve Phage Display Library-Derived Nanobody Neutralizes SARS-CoV-2 and Three Variants of Concern." in: International journal of nanomedicine, Vol. 18, pp. 5781-5795, (2023) (PubMed).
: "Antibody escape and global spread of SARS-CoV-2 lineage A.27." in: Nature communications, Vol. 13, Issue 1, pp. 1152, (2022) (PubMed).
: "A Structurally Conserved RNA Element within SARS-CoV-2 ORF1a RNA and S mRNA Regulates Translation in Response to Viral S Protein-Induced Signaling in Human Lung Cells." in: Journal of virology, Vol. 96, Issue 2, pp. e0167821, (2022) (PubMed).
: "Within-host evolution of SARS-CoV-2 in an immunosuppressed COVID-19 patient as a source of immune escape variants." in: Nature communications, Vol. 12, Issue 1, pp. 6405, (2021) (PubMed).
: "Enhancing the Stability of COVID-19 Serological Assay through Metal-Organic Framework Encapsulation." in: Advanced healthcare materials, Vol. 10, Issue 18, pp. e2100410, (2021) (PubMed).
: "Rotavirus as an Expression Platform of the SARS-CoV-2 Spike Protein." in: bioRxiv : the preprint server for biology, (2021) (PubMed).
: "Tissue-Based SARS-Cov-2 Detection in Fatal COVID-19 Infections: Sustained Direct Viral-Induced Damage is Not Necessary to Drive Disease Progression. ..." in: Human pathology, (2021) (PubMed).
: "High-throughput fabrication of high aspect ratio Ag/Al nanopillars for optical detection of biomarkers." in: Journal of materials chemistry. B, (2021) (PubMed).
: "Complement associated microvascular injury and thrombosis in the pathogenesis of severe COVID-19 infection: A report of five cases." in: Translational research : the journal of laboratory and clinical medicine, Vol. 220, pp. 1-13, (2020) (PubMed).
Aliases for SARS-CoV-2 Spike 抗体
E2 glycoprotein precursor (S) 抗体Surface Glycoprotein (S) 抗体
E2 抗体
您还需要查找其他产品吗？
- SARS-CoV-2 Nucleocapsid 抗体
- SARS-CoV-2 NSP5 (3CL-Pro) 抗体
- SARS-CoV-2 NSP13 抗体
- SARS-CoV-2 NSP12 (RdRP) 抗体
- SARS-CoV-2 Non-Structural Protein 9 抗体
- SARS-CoV-2 Non-Structural Protein 8 抗体
- SARS-CoV Spike 抗体
- SARS-Coronavirus Nucleocapsid Protein 抗体
- SARS-Coronavirus Nonstructural Protein 8 抗体
- SARS-Coronavirus Membrane Protein 抗体
- SARNP 抗体
- SARM1 抗体
- SARDH 抗体
- Sarcolemma Associated Protein 抗体
- Sarcalumenin 抗体
- SAR1B 抗体
- SAR1A 抗体
- SAPS2 抗体
- SAPS1 抗体
- SAP30BP 抗体
You are here:
